Latest News & Features
Americas
Japan-based Takeda Pharmaceutical has acquired Ariad Pharmaceuticals, a company which develops small-molecule medicines for cancer treatments, for $5.2 billion. 11 January 2017
Americas
The US Court of Appeals for the Federal Circuit has reversed and remanded a patent dispute centring on a cannulated scalpel, a method of knee surgery. 11 January 2017
Americas
Pharmaceutical research company Phigenix lost an appeal at the US Court of Appeals for the Federal Circuit yesterday, after the court found that the company lacked standing in a patent case against ImmunoGen. 10 January 2017
Americas
Sanofi and Regeneron Pharmaceuticals have revealed plans to appeal against an injunction granted to Amgen, which prevents the companies from selling cholesterol-lowering medicine Praluent. 9 January 2017
Americas
Sanofi and Regeneron Pharmaceuticals must stop selling cholesterol-lowering medicine Praluent after Amgen obtained an injunction against the companies. 6 January 2017
Americas
Healthcare company Fresenius Kabi has targeted Sagent Pharmaceuticals in a patent infringement lawsuit centring on generic versions of Naropin. 6 January 2017
Biotechnology
The English High Court has dismissed an application for summary judgment from pharmaceutical company AbbVie. 6 January 2017
Americas
US-based law firm Offit Kurman has boosted its expertise in Virginia with the appointment of Christopher Raimund as a principal in the intellectual property practice. 5 January 2017
Americas
Par Pharmaceutical has sought a declaratory judgment that it did not infringe patents belonging to Sumitomo and its subsidiary Sunovion that protect bipolar disorder drug Latuda. 5 January 2017
Americas
The US Court of Appeals for the Federal Circuit has affirmed a Patent Trial and Appeal Board decision that said patent claims owned by Ethicon, a subsidiary of Johnson & Johnson (J&J), are invalid. 4 January 2017